Ginkgo Bioworks Holdings DNA paid Forbes-Tate $40K for lobbying in Q2 2023 · Health Issues, Science and 2 more issues

Trade details

Type: Lobbying report
Amount: $40,000
Quarter: Q2 2023
Stock: Ginkgo Bioworks Holdings DNA
Client: Ginkgo Bioworks
Reported: 23/07/16

Down 50.0% from last quarter

What else happened in Ginkgo Bioworks Holdings around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Ginkgo Bioworks's other lobbying reports

Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 07/18
for Q2
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 07/10
for Q2
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 04/20
for Q1
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 04/15
for Q1
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$30K
$30K
Reported 01/20
for Q4 2025

Ginkgo Bioworks Holdings DNA paid Forbes-Tate $40K for lobbying in Q2 2023 · Health Issues, Science and 2 more issues | Whalegun